FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008743974> ?p ?o ?g. }

• W2008743974 endingPage "73" @default.
• W2008743974 startingPage "62" @default.
• W2008743974 abstract "Nuclear-cytoplasmic trafficking of proteins is a significant factor in the development of cancer and drug resistance. Subcellular localization of exported proteins linked to cancer development include those involved in cell growth and proliferation, apoptosis, cell cycle regulation, transformation, angiogenesis, cell adhesion, invasion, and metastasis. Here, we examined the basic mechanisms involved in the export of proteins from the nucleus to the cytoplasm. All proteins over 40kDa use the nuclear pore complex to gain entry or exit from the nucleus, with the primary nuclear export molecule involved in these processes being chromosome region maintenance 1 (CRM1, exportin 1 or XPO1). Proteins exported from the nucleus must possess a hydrophobic nuclear export signal (NES) peptide that binds to a hydrophobic groove containing an active-site Cys528 in the CRM1 protein. CRM1 inhibitors function largely by covalent modification of the active site Cys528 and prevent binding to the cargo protein NES. In the absence of a CRM1 inhibitor, CRM1 binds cooperatively to the NES of the cargo protein and RanGTP, forming a trimer that is actively transported out of the nucleus by facilitated diffusion. Nuclear export can be blocked by CRM1 inhibitors, NES peptide inhibitors or by preventing post-translational modification of cargo proteins. Clinical trials using the classic CRM1 inhibitor leptomycin B proved too toxic for patients; however, a new generation of less toxic small molecule inhibitors is being used in clinical trials in patients with both hematological malignancies and solid tumors. Additional trials are being initiated using small-molecule CRM1 inhibitors in combination with chemotherapeutics such as pegylated liposomal doxorubicin. In this review, we present evidence that combining the new CRM1 inhibitors with other classes of therapeutics may prove effective in the treatment of cancer. Potential combinatorial therapies discussed include the use of CRM1 inhibitors and the addition of alkylating agents (melphalan), anthracyclines (doxorubicin and daunomycin), BRAF inhibitors, platinum drugs (cisplatin and oxaliplatin), proteosome inhibitors (bortezomib and carfilzomib), or tyrosine-kinase inhibitors (imatinib). Also, the sequence of treatment may be important for combination therapy. We found that the most effective treatment regimen involved first priming the cancer cells with the CRM1 inhibitor followed by doxorubicin, bortezomib, carfilzomib, or melphalan. This order sensitized both de novo and acquired drug-resistant cancer cell lines." @default.
• W2008743974 created "2016-06-24" @default.
• W2008743974 creator A5021617351 @default.
• W2008743974 creator A5033566009 @default.
• W2008743974 creator A5035721135 @default.
• W2008743974 creator A5077110117 @default.
• W2008743974 creator A5084739733 @default.
• W2008743974 date "2014-08-01" @default.
• W2008743974 modified "2023-10-18" @default.
• W2008743974 title "Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents" @default.
• W2008743974 cites W100225602 @default.
• W2008743974 cites W1480534106 @default.
• W2008743974 cites W1509669696 @default.
• W2008743974 cites W1827357122 @default.
• W2008743974 cites W1886811574 @default.
• W2008743974 cites W1926593386 @default.
• W2008743974 cites W1964824076 @default.
• W2008743974 cites W1965253007 @default.
• W2008743974 cites W1970954347 @default.
• W2008743974 cites W1971961101 @default.
• W2008743974 cites W1975776751 @default.
• W2008743974 cites W1977558343 @default.
• W2008743974 cites W1978968003 @default.
• W2008743974 cites W1981800752 @default.
• W2008743974 cites W1982620171 @default.
• W2008743974 cites W1985163885 @default.
• W2008743974 cites W1986546541 @default.
• W2008743974 cites W1987851045 @default.
• W2008743974 cites W1988100051 @default.
• W2008743974 cites W1993595529 @default.
• W2008743974 cites W1993803213 @default.
• W2008743974 cites W1994286631 @default.
• W2008743974 cites W1994609337 @default.
• W2008743974 cites W1996451804 @default.
• W2008743974 cites W1999514723 @default.
• W2008743974 cites W2001956327 @default.
• W2008743974 cites W2002403054 @default.
• W2008743974 cites W2004136552 @default.
• W2008743974 cites W2009386327 @default.
• W2008743974 cites W2012859437 @default.
• W2008743974 cites W2016153572 @default.
• W2008743974 cites W2016397716 @default.
• W2008743974 cites W2016406151 @default.
• W2008743974 cites W2018348035 @default.
• W2008743974 cites W2021789806 @default.
• W2008743974 cites W2022416092 @default.
• W2008743974 cites W2023690797 @default.
• W2008743974 cites W2025658684 @default.
• W2008743974 cites W2028885314 @default.
• W2008743974 cites W2029952484 @default.
• W2008743974 cites W2031369019 @default.
• W2008743974 cites W2033004457 @default.
• W2008743974 cites W2039415210 @default.
• W2008743974 cites W2039498818 @default.
• W2008743974 cites W2039650326 @default.
• W2008743974 cites W2045332195 @default.
• W2008743974 cites W2046497407 @default.
• W2008743974 cites W2046997182 @default.
• W2008743974 cites W2047222465 @default.
• W2008743974 cites W2050931918 @default.
• W2008743974 cites W2051290129 @default.
• W2008743974 cites W2051520394 @default.
• W2008743974 cites W2052273234 @default.
• W2008743974 cites W2053691647 @default.
• W2008743974 cites W2054645565 @default.
• W2008743974 cites W2054857305 @default.
• W2008743974 cites W2055160887 @default.
• W2008743974 cites W2056199226 @default.
• W2008743974 cites W2061981026 @default.
• W2008743974 cites W2062233810 @default.
• W2008743974 cites W2065629980 @default.
• W2008743974 cites W2067635683 @default.
• W2008743974 cites W2073109412 @default.
• W2008743974 cites W2073681698 @default.
• W2008743974 cites W2077682572 @default.
• W2008743974 cites W2082627972 @default.
• W2008743974 cites W2082739624 @default.
• W2008743974 cites W2094741094 @default.
• W2008743974 cites W2096890855 @default.
• W2008743974 cites W2099508205 @default.
• W2008743974 cites W2099970679 @default.
• W2008743974 cites W2105544978 @default.
• W2008743974 cites W2106602239 @default.
• W2008743974 cites W2108442683 @default.
• W2008743974 cites W2109882555 @default.
• W2008743974 cites W2112595206 @default.
• W2008743974 cites W2112632901 @default.
• W2008743974 cites W2114261502 @default.
• W2008743974 cites W2114906163 @default.
• W2008743974 cites W2114915170 @default.
• W2008743974 cites W2117692326 @default.
• W2008743974 cites W2118040139 @default.
• W2008743974 cites W2118411078 @default.
• W2008743974 cites W2119483030 @default.
• W2008743974 cites W2121045332 @default.
• W2008743974 cites W2122263758 @default.
• W2008743974 cites W2123017967 @default.
• W2008743974 cites W2123408027 @default.

• next